This Article Full Text Full Text (PDF) All Versions of this Article: 27/5/1153    most recent ATVBAHA.106.136325v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Birjmohun, R. S. Articles by Stroes, E. S.G. Search for Related Content PubMed PubMed Citation Articles by Birjmohun, R. S. Articles by Stroes, E. S.G.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:1153.)
© 2007 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

High-Density Lipoprotein Attenuates Inflammation and Coagulation Response on Endotoxin Challenge in Humans

Rakesh S. Birjmohun; Sander I. van Leuven; Johannes H.M. Levels; Cornelis van ‘t Veer; Jan Albert Kuivenhoven; Joost C.M. Meijers; Marcel Levi; John J.P. Kastelein; Tom van der Poll; Erik S.G. Stroes

From the Departments of Vascular Medicine (R.S.B., S.I.v.L., J.H.M.L., J.A.K., J.C.M.M., M.L., J.J.P.K., E.S.G.S.) and Center for Experimental and Molecular Medicine (C.v.t.V., T.v.d.P.), Academic Medical Center, Amsterdam, the Netherlands.

Correspondence to Erik S.G. Stroes, MD, PhD, Academic Medical Center of Amsterdam, Department of Vascular Medicine, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. E-mail e.s.stroes{at}amc.uva.nl

Objective— Low high-density lipoprotein (HDL) cholesterol is a strong independent cardiovascular risk factor, which has been attributed to its role in reverse cholesterol transport. Whereas HDL also has potent antiinflammatory effects, the relevance of this property remains to be established in humans. In the present study, we evaluated whether there is a relation between HDL and sensitivity toward a low-dose endotoxin challenge.

Methods and Results— Thirteen healthy men with genetically determined isolated low HDL cholesterol (averaging 0.7±0.1 mmol/L) and 14 age- and body weight-matched healthy men with normal/high HDL cholesterol levels (1.9±0.4 mmol/L) were challenged with low-dose endotoxin intravenously (1 ng/kg body weight). The incidence and severity of endotoxin-associated clinical symptoms was increased in the low HDL group. Accordingly, both the inflammatory response (tumor necrosis factor-, IL-1β, IL-6, IL-8, and monocyte chemoattractant protein-1) as well as thrombin generation (prothrombin activation fragments F₁₊₂) were significantly increased in the low HDL group on endotoxin challenge.

Conclusions— Low HDL in healthy males is associated with increased sensitivity toward inflammatory stimuli as reflected by enhanced inflammatory and coagulation responses on endotoxin challenge. These antiinflammatory effects of HDL in humans may lend further support to HDL-increasing interventions, particularly in proinflammatory conditions, such as acute coronary syndromes.

Low high-density lipoprotein (HDL) cholesterol is a strong independent cardiovascular risk factor, which has been attributed to its role in reverse cholesterol transport. Whereas HDL also has potent antiinflammatory effects, the relevance of this property remains to be established in humans. In the present study, we evaluated whether there is a relation between HDL and sensitivity toward a low-dose endotoxin challenge.

Key Words: cholesterol • coagulation • inflammation • lipoproteins • thrombosis

This article has been cited by other articles:

				R.-C. Huang, T. A. Mori, V. Burke, J. Newnham, F. J. Stanley, L. I. Landau, G. E. Kendall, W. H. Oddy, and L. J. Beilin Synergy Between Adiposity, Insulin Resistance, Metabolic Risk Factors, and Inflammation in Adolescents Diabetes Care, April 1, 2009; 32(4): 695 - 701. [Abstract] [Full Text] [PDF]

				T. Gautier, A. Klein, V. Deckert, C. Desrumaux, N. Ogier, A.-L. Sberna, C. Paul, N. Le Guern, A. Athias, T. Montange, et al. Effect of Plasma Phospholipid Transfer Protein Deficiency on Lethal Endotoxemia in Mice J. Biol. Chem., July 4, 2008; 283(27): 18702 - 18710. [Abstract] [Full Text] [PDF]

				M. Westerterp, J. F.P. Berbee, N. M.M. Pires, G. J.D. van Mierlo, R. Kleemann, J. A. Romijn, L. M. Havekes, and P. C.N. Rensen Apolipoprotein C-I Is Crucially Involved in Lipopolysaccharide-Induced Atherosclerosis Development in Apolipoprotein E Knockout Mice Circulation, November 6, 2007; 116(19): 2173 - 2181. [Abstract] [Full Text] [PDF]